• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

小鼠和人类巨噬细胞移动抑制因子(MIF)的纯化、生物活性及二级结构分析

Purification, bioactivity, and secondary structure analysis of mouse and human macrophage migration inhibitory factor (MIF).

作者信息

Bernhagen J, Mitchell R A, Calandra T, Voelter W, Cerami A, Bucala R

机构信息

Picower Institute for Medical Research, Manhasset, New York 11030.

出版信息

Biochemistry. 1994 Nov 29;33(47):14144-55. doi: 10.1021/bi00251a025.

DOI:10.1021/bi00251a025
PMID:7947826
Abstract

The cytokine macrophage migration inhibitory factor (MIF) has been identified to be secreted by the pituitary gland and the monocyte/macrophage and to play an important role in endotoxic shock. Despite the recent molecular cloning of a human T-cell MIF, characterization of the biochemical and biological properties of this protein has remained incomplete because substantial quantities of purified, recombinant, or native MIF have not been available. We describe the cloning of mouse MIF from anterior pituitary cells (AtT-20) and the purification of native MIF from mouse liver by sequential ion exchange and reverse-phase chromatography. For comparison purposes, human MIF was cloned from the Jurkat T-cell line and also characterized. Mouse and human MIF were highly homologous (90% identity over 115 amino acids). Recombinant mouse and human MIF were expressed in Escherichia coli and purified in milligram quantities by a simple two-step procedure. The molecular weight of native mouse MIF (12.5 kDa monomer) was identical with that of recombinant mouse MIF as assessed by gel electrophoresis and mass spectroscopy. No significant post-translational modifications were detected despite the presence of two potential N-linked glycosylation sites. Recombinant MIF inhibited monocyte migration in a dose-dependent fashion, and both recombinant and native MIF-exhibited comparable biological activities. MIF induced the secretion of tumor necrosis factor-alpha and stimulated nitric oxide production by macrophages primed with interferon-gamma. Circular dichroism spectroscopy revealed that bioactive mouse and human MIF exhibit a highly ordered, three-dimensional structure with a significant percentage of beta-sheet and alpha-helix conformation. Guanidine hydrochloride-induced unfolding experiments demonstrated that MIF is of low to moderate thermodynamic stability. These studies establish the biochemical identity of native and recombinant MIF and provide a first insight into the three-dimensional structural properties of this critical inflammatory mediator.

摘要

细胞因子巨噬细胞移动抑制因子(MIF)已被证实由垂体以及单核细胞/巨噬细胞分泌,并在内毒素休克中发挥重要作用。尽管近期已对人T细胞MIF进行了分子克隆,但由于无法获得大量纯化的、重组的或天然的MIF,该蛋白的生化及生物学特性的表征仍不完整。我们描述了从小鼠垂体前叶细胞(AtT-20)克隆小鼠MIF以及通过连续离子交换和反相色谱法从鼠肝中纯化天然MIF的过程。为作比较,我们还从Jurkat T细胞系克隆了人MIF并对其进行了表征。小鼠和人MIF高度同源(在115个氨基酸上有90%的同一性)。重组小鼠和人MIF在大肠杆菌中表达,并通过一个简单的两步程序纯化出毫克量的蛋白。通过凝胶电泳和质谱评估,天然小鼠MIF(12.5 kDa单体)的分子量与重组小鼠MIF相同。尽管存在两个潜在的N-连接糖基化位点,但未检测到明显的翻译后修饰。重组MIF以剂量依赖方式抑制单核细胞迁移,重组MIF和天然MIF均表现出相当的生物学活性。MIF诱导肿瘤坏死因子-α的分泌,并刺激经γ干扰素预处理的巨噬细胞产生一氧化氮。圆二色光谱显示,具有生物活性的小鼠和人MIF呈现高度有序的三维结构,其中β折叠和α螺旋构象占相当比例。盐酸胍诱导的去折叠实验表明,MIF具有低至中等的热力学稳定性。这些研究确定了天然和重组MIF的生化特性,并首次深入了解了这种关键炎症介质的三维结构特性。

相似文献

1
Purification, bioactivity, and secondary structure analysis of mouse and human macrophage migration inhibitory factor (MIF).小鼠和人类巨噬细胞移动抑制因子(MIF)的纯化、生物活性及二级结构分析
Biochemistry. 1994 Nov 29;33(47):14144-55. doi: 10.1021/bi00251a025.
2
High-yield expression and purification of recombinant human macrophage migration inhibitory factor.
Protein Expr Purif. 1997 Feb;9(1):115-24. doi: 10.1006/prep.1996.0641.
3
The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor.巨噬细胞是巨噬细胞迁移抑制因子的一个重要且此前未被认识到的来源。
J Exp Med. 1994 Jun 1;179(6):1895-902. doi: 10.1084/jem.179.6.1895.
4
Macrophage migration inhibitory factor (MIF): a glucocorticoid counter-regulator within the immune system.巨噬细胞移动抑制因子(MIF):免疫系统内的一种糖皮质激素反调节因子。
Crit Rev Immunol. 1997;17(1):77-88. doi: 10.1615/critrevimmunol.v17.i1.30.
5
Macrophage migration inhibitory factor of the parasitic nematode Trichinella spiralis.旋毛虫巨噬细胞移动抑制因子
Biochem J. 2001 Jul 15;357(Pt 2):373-83. doi: 10.1042/0264-6021:3570373.
6
Purification and characterization of human macrophage migration inhibitory factor: evidence for specific binding to glutathione and formation of subunit structure.人巨噬细胞迁移抑制因子的纯化与特性分析:与谷胱甘肽特异性结合及亚基结构形成的证据
Biochem Mol Biol Int. 1993 Dec;31(5):841-50.
7
Mechanistic differences between migration inhibitory factor (MIF) and IFN-gamma for macrophage activation. MIF and IFN-gamma synergize with lipid A to mediate migration inhibition but only IFN-gamma induces production of TNF-alpha and nitric oxide.迁移抑制因子(MIF)与γ干扰素在巨噬细胞激活方面的机制差异。MIF和γ干扰素与脂多糖协同作用以介导迁移抑制,但只有γ干扰素能诱导肿瘤坏死因子-α(TNF-α)和一氧化氮的产生。
J Immunol. 1993 May 15;150(10):4524-31.
8
Molecular cloning and functional characterization of the avian macrophage migration inhibitory factor (MIF).禽类巨噬细胞移动抑制因子(MIF)的分子克隆与功能鉴定。
Dev Comp Immunol. 2010 Sep;34(9):1021-32. doi: 10.1016/j.dci.2010.05.005. Epub 2010 May 20.
9
Macrophage Migration Inhibitory Factor (MIF): A Glucocorticoid Counter-Regulator within the Immune System.巨噬细胞移动抑制因子(MIF):免疫系统内的一种糖皮质激素反调节因子。
Crit Rev Immunol. 2017;37(2-6):359-370. doi: 10.1615/CritRevImmunol.v37.i2-6.90.
10
Cloning and characterization of the gene for mouse macrophage migration inhibitory factor (MIF).小鼠巨噬细胞移动抑制因子(MIF)基因的克隆与特性分析
J Immunol. 1995 Apr 15;154(8):3863-70.

引用本文的文献

1
Macrophage migration inhibitory factor: Exploring physiological roles and comparing health benefits against oncogenic and autoimmune risks (Review).巨噬细胞移动抑制因子:探索生理作用并比较其对致癌风险和自身免疫风险的健康益处(综述)
Int J Mol Med. 2025 Oct;56(4). doi: 10.3892/ijmm.2025.5590. Epub 2025 Jul 19.
2
MIF functional polymorphisms are associated with acute GVHD progression and steroid-refractoriness.巨噬细胞移动抑制因子功能多态性与急性移植物抗宿主病的进展及激素抵抗相关。
Front Immunol. 2025 Apr 30;16:1504976. doi: 10.3389/fimmu.2025.1504976. eCollection 2025.
3
An atypical atherogenic chemokine that promotes advanced atherosclerosis and hepatic lipogenesis.
一种促进晚期动脉粥样硬化和肝脏脂肪生成的非典型致动脉粥样硬化趋化因子。
Nat Commun. 2025 Mar 7;16(1):2297. doi: 10.1038/s41467-025-57540-z.
4
The VEGF-Mediated Cytoprotective Ability of MIF-Licensed Mesenchymal Stromal Cells in House Dust Mite-Induced Epithelial Damage.巨噬细胞移动抑制因子许可的间充质基质细胞在屋尘螨诱导的上皮损伤中的血管内皮生长因子介导的细胞保护能力
Eur J Immunol. 2025 Jan;55(1):e202451205. doi: 10.1002/eji.202451205. Epub 2024 Nov 6.
5
Therapeutic Opportunities in Breast Cancer by Targeting Macrophage Migration Inhibitory Factor as a Pleiotropic Cytokine.通过靶向巨噬细胞移动抑制因子这一多功能细胞因子探索乳腺癌的治疗新机遇
Breast Cancer (Auckl). 2024 Sep 6;18:11782234241276310. doi: 10.1177/11782234241276310. eCollection 2024.
6
CD74 is a functional MIF receptor on activated CD4 T cells.CD74 是激活的 CD4 T 细胞上功能性的 MIF 受体。
Cell Mol Life Sci. 2024 Jul 11;81(1):296. doi: 10.1007/s00018-024-05338-5.
7
Downregulation of adipose LPL by PAR2 contributes to the development of hypertriglyceridemia.蛋白酶激活受体 2(PAR2)下调脂肪组织脂蛋白脂肪酶(LPL)导致甘油三酯血症的发生。
JCI Insight. 2024 Jul 8;9(13):e173240. doi: 10.1172/jci.insight.173240.
8
The Role of Macrophage Migration Inhibitory Factor (MIF) and D-Dopachrome Tautomerase (D-DT/MIF-2) in Infections: A Clinical Perspective.巨噬细胞移动抑制因子(MIF)和D-多巴色素互变异构酶(D-DT/MIF-2)在感染中的作用:临床视角
Biomedicines. 2023 Dec 19;12(1):2. doi: 10.3390/biomedicines12010002.
9
Macrophage migration inhibitory factor receptor CD74 expression is associated with expansion and differentiation of effector T cells in COVID-19 patients.巨噬细胞移动抑制因子受体 CD74 的表达与 COVID-19 患者效应 T 细胞的扩增和分化有关。
Front Immunol. 2023 Oct 25;14:1236374. doi: 10.3389/fimmu.2023.1236374. eCollection 2023.
10
MIF-like domain containing protein orchestrates cellular differentiation and virulence in the fungal pathogen .含MIF样结构域蛋白调控真菌病原体的细胞分化和毒力。
iScience. 2023 Aug 6;26(9):107565. doi: 10.1016/j.isci.2023.107565. eCollection 2023 Sep 15.